| Long term morbidity of neoadjuvant chemoradiation for pancreatic head adenocarcinoma. | |
| | |
MedLine Citation:
|
PMID: 16305820 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To report the long term risks of neoadjuvant chemoradiation (NCRT) after duodenopancreatectomy (DP) for adenocarcinoma of the head of pancreas. METHODS: Between January 1996 and December 2002, 26 patients with biopsy-proven adenocarcinoma of the head of pancreas were treated by this combination of therapies. RESULTS: Two patients had delayed NCRT-related small bowel infarction: one died from superior mesenteric artery stenosis 36 months after DP without recurrence at laparotomy; there was one limited infarction 16 months after DP. CONCLUSIONS: Long term vascular morbidity after NCRT is significant. |
| | |
Authors:
|
O Turrini; V Moutardier; J Guiramand; F Viret; M Giovaninni; J R Delpero |
Publication Detail:
|
Type: Comparative Study; Journal Article Date: 2005-11-21 |
Journal Detail:
|
Title: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology Volume: 32 ISSN: 0748-7983 ISO Abbreviation: Eur J Surg Oncol Publication Date: 2006 Feb |
Date Detail:
|
Created Date: 2006-01-23 Completed Date: 2006-03-16 Revised Date: 2007-07-02 |
Medline Journal Info:
|
Nlm Unique ID: 8504356 Medline TA: Eur J Surg Oncol Country: England |
Other Details:
|
Languages: eng Pagination: 77-9 Citation Subset: IM |
Affiliation:
|
Department of Surgical Oncology, Institut Paoli-Calmettes Marseille, 232 Boulevard Ste Marguerite, 13009 Marseille, France. oturrini@yahoo.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenocarcinoma
/
drug therapy,
epidemiology*,
radiotherapy Antineoplastic Agents / therapeutic use Biopsy Follow-Up Studies Humans Morbidity Neoadjuvant Therapy Pancreas / pathology, ultrasonography Pancreatic Neoplasms / drug therapy, epidemiology*, radiotherapy Pancreaticoduodenectomy Retrospective Studies Survival Rate Time Factors Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Leptin secretion in horses: effects of dexamethasone, gender, and testosterone.
Next Document: The prognosis of patients with local recurrence more than five years after breast conservation thera...